Your browser doesn't support javascript.
loading
Ritonavir and efavirenz significantly alter the metabolism of erlotinib--an observation in primary cultures of human hepatocytes that is relevant to HIV patients with cancer.
Pillai, Venkateswaran C; Venkataramanan, Raman; Parise, Robert A; Christner, Susan M; Gramignoli, Roberto; Strom, Stephen C; Rudek, Michelle A; Beumer, Jan H.
Afiliação
  • Pillai VC; Department of Pharmaceutical Sciences and Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania (V.C.P., R.V.); Molecular Therapeutics Drug Discovery program, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania (R.A.P., S.M.C., J.H.B.); Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet and Hospital, Stockholm, Sweden (R.G., S.C.S.); and The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland
Drug Metab Dispos ; 41(10): 1843-51, 2013 Oct.
Article em En | MEDLINE | ID: mdl-23913028

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinazolinas / Infecções por HIV / Ritonavir / Hepatócitos / Benzoxazinas / Interações Medicamentosas / Neoplasias Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2013 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinazolinas / Infecções por HIV / Ritonavir / Hepatócitos / Benzoxazinas / Interações Medicamentosas / Neoplasias Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2013 Tipo de documento: Article